Perella Weinberg
Perella Weinberg Partners is an independent, privately-owned financial services firm that provides corporate advisory and asset management services to clients around the world. The Firm has assembled a group of talented and experienced professionals recruited from a wide variety of leading global financial institutions.
View Older Stories View More Recent Stories
-
Alpha Teknova (TNKO) IPO Opens 29.5% Higher
-
Alpha Teknova, Inc. (TKNO) Prices 6M Share IPO at $16/sh
-
Teknova Announces Pricing of its Upsized Initial Public Offering
-
Teknova Announces Pricing of its Upsized Initial Public Offering
-
Form 25-NSE Perella Weinberg Partner Filed by: Nasdaq Stock Market LLC
-
Perella Weinberg Partners (PWP) Completes Business Combination With FinTech Acquisition Corp. IV (FTIV)
-
Perella Weinberg Partners Completes Business Combination With FinTech Acquisition Corp. IV
-
FinTech Acquisition Corp. IV Announces Stockholders Approve Business Combination With Perella Weinberg Partners
-
Repligen (RGEN) to Acquire Polymem S.A.
-
Repligen Corporation Announces Agreement to Acquire Polymem S.A.
-
Pershing Square Tontine (PSTH) Acquires 10% of Universal Music Group for $4B
-
Pershing Square Holdings, Ltd. Provides Update to Investors
-
Pershing Square Tontine Holdings, Ltd. (“PSTH”) to Acquire 10% of the Ordinary Shares of Universal Music Group (“UMG”) from Vivendi S.E. for Approximately $4 billion, Representing an Enterpris
-
Aditx Therapeutics Inc. (ADTX) Announces Appointment of Dr. Lauren Chung to its Board of Directors
-
Aditxt Announces the Appointment of Dr. Lauren Chung to its Board of Directors
-
Cronos Group (CRON) to Invest in U.S. Cannabis Company PharmaCann
-
Cronos Group (CRON) Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company
-
Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company
-
Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company
-
Cronos Group Inc. (CRON) Announces Strategic Investment in PharmaCann
-
SHAREHOLDER ALERT: WeissLaw LLP Reminds FTIV, PMBC, SVBI, and CNBKA Shareholders About Its Ongoing Investigations
-
CENTR Brands Corp. Hires Carlyle Group Executive David Young as CFO
-
SHAREHOLDER ALERT: WeissLaw LLP Reminds FTIV, PMBC, SVBI and CNBKA Shareholders About Its Ongoing Investigations
-
Bouygues: Bouygues Successfully Completes Sale of Alstom Shares
-
Top Credit Suisse European FIG banker joins Jefferies -sources
-
Cloudera Inc. (CLDR) Confirms Deal to Be Acquired by Clayton, Dubilier & Rice and KKR for $5.3B
-
Cloudera Enters into Definitive Agreement to be Acquired by Clayton, Dubilier & Rice and KKR for $5.3 Billion
-
FinTech Acquisition Corp. IV Announces Special Meeting Date for Proposed Business Combination with Perella Weinberg Partners
-
KKR, CD&R take data analytics firm Cloudera private for $4.7 billion
-
Cloudera (CLDR) Enters into Definitive Agreement to be Acquired by Clayton, Dubilier & Rice and KKR for $5.3 Billion
-
SHAREHOLDER ALERT: WeissLaw LLP Reminds WRI, VKIN, GNBF, and FTIV Shareholders About Its Ongoing Investigations
-
Germany's biggest landlords seek to reassure Berliners over $22 billion merger
-
Gulfport Energy Corporation Successfully Emerges From Chapter 11
-
AT&T set to end media voyage with $43 billion Discovery deal
-
Aerpio Pharmaceuticals (ARPO) and Aadi Bioscience Enter into a Definitive Merger Agreement
-
Perella Weinberg Partners Reports First Quarter 2021 Results
-
Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive Merger Agreement
-
Perella Weinberg Partners Announces First Quarter 2021 Earnings Conference Call Details
-
Form 13F-HR Perella Weinberg Partner For: Mar 31
-
Christian Bradeen to Join Perella Weinberg Partners as Partner
-
Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp. (LSAQ)
-
Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future
-
Becton Dickinson (BDX) to Spin Off Diabetes Care Business
-
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
-
Inivata to be Acquired by NeoGenomics
-
NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
-
Valaris plc (VAL) Successfully Completes Restructuring
-
Valaris Successfully Completes Restructuring
-
Garrett Motion Successfully Completes Chapter 11 Restructuring With New Capital and Strong Balance Sheet
-
Origin Materials to Participate in Upcoming Investor Conferences

